menu search

Memecoin mooky raises $900,000 ahead of its final presale stage

­­Memecoin Mooky is gearing up for its final presale phase, having raised $900,000 to date. More than just a ...

June 30, 2023, 11:39 am

The cashless society: a paradigm shift in financial transactions

In recent years, there has been a substantial shift in the way we perform financial transactions. The development of digital payment methods and the i...

June 29, 2023, 12:57 pm

Regtech innovations: transforming compliance in the digital age

Regulatory compliance has become a challenging task for organizations across industries in today's quickly expanding digital landscape. The emergence ...

June 28, 2023, 2:12 pm

Axsome therapeutics announces proposed public offering of common stock

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM) (“Axsome” or the “Company”), a biopharmaceutical company...

June 28, 2023, 12:24 am

The privacy layer for web3, iron fish, launches node application, enabling privacy-conscious users to run a full node in one click

SAN FRANCISCO, June 27, 2023 (GLOBE NEWSWIRE) — Iron Fish, a fully private, proof-of-work (PoW) based layer 1 blockchain with built-in compliance fe...

June 27, 2023, 2:30 pm

Amyotrophic lateral sclerosis treatment market to reach us$ 594.1 million in 2031, expanding at a cagr of 5.5%: tmr report

Increased consumer and medical professional knowledge regarding novel treatments is predicted to drive ...

June 26, 2023, 5:30 pm

Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model

Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...

June 24, 2023, 12:00 pm

Pliant therapeutics presents data from its bexotegrast program at the european association for the study of the liver (easl) international liver congress™

Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis SOUTH SAN FRANCISCO, Calif., Ju...

June 23, 2023, 11:30 am

Disc medicine announces closing of public offering of common stock and pre-funded warrants including full exercise of underwriters’ option to purchase additional shares

WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on ...

June 22, 2023, 8:15 pm

Mindset pharma's phase 2 psilocin prodrug study gets green light from uk regulators

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has received approval from the UK Medicines and Healthcare products Regulatory Authority and the Research E...

June 22, 2023, 10:45 am

Nextcure presents non-clinical data defining the mechanism of nc525 at the 2023 federation of clinical immunology societies (focis) annual meeting

BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering...

June 21, 2023, 8:05 pm

Vaccitech to present positive final data at easl congress for phase 1b/2 hbv002 study in adults with chronic hepatitis b

OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc...

June 21, 2023, 9:03 am

Arbutus presents preliminary ab-729 and pegylated interferon alfa-2a combination data at the easl congress 2023

Treatment was generally well tolerated with continued HBsAg declines in some patients WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE) — Arbutus Biop...

June 21, 2023, 6:01 am

Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023

New clinical data from COVALENT-111 will be unveiled during a late-breaking poster presentation at ADA’s Scientific Sessions BMF-219, an orally deli...

June 20, 2023, 8:30 pm

Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023

REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company ...

June 20, 2023, 4:30 pm

Cognition therapeutics invited to participate on panel during cantor fitzgerald brain week 2023 on novel alzheimer’s disease approaches

PURCHASE, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today...

June 20, 2023, 11:30 am

Attovia therapeutics launches with $60 million series a financing to unlock potential of novel biparatopic nanobody platform

Company Formed by Alamar Biosciences and Frazier Life Sciences Attobody™ Platform Generates Small Format Binders for Hard-to-drug Targets FREMONT, C...

June 20, 2023, 11:30 am

Helius medical technologies announces dmepos accreditation for pons

— Critical initial step toward US reimbursement — NEWTOWN, Pa., June 20, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT)...

June 20, 2023, 11:05 am

Iovance biotherapeutics to host virtual roundtable with key opinion leaders to discuss melanoma treatment landscape

Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET SAN CARLOS, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (...

June 20, 2023, 11:01 am


Search within

Pages Search Results: